title: Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women.
authors.affiliation: *Grady Memorial Hospital and Emory University School of Medicine, Department of Medicine, Division of Infectious Diseases, and Department of Gynecology and Obstetrics, Atlanta, GA †Albert Einstein College of Medicine, Department of Epidemiology and Population Health, Bronx, NY ‡Washington University School of Medicine, Department of Obstetrics and Gynecology, St. Louis, MO §University of Alabama, Department of Pathology, Birmingham, AL ‖Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD ¶University of California, Department of Medicine, Division of Infectious Diseases, San Francisco, CA #University of North Carolina School of Medicine, Department of Obstetrics and Gynecology, Chapel Hill, NC.
authors.forename: Cecile D
authors.initials: CD
authors.lastname: Lahiri
authors.forename: Katherine B
authors.initials: KB
authors.lastname: Dugan
authors.forename: Xianhong
authors.initials: X
authors.lastname: Xie
authors.forename: Laura
authors.initials: L
authors.lastname: Reimers
authors.forename: Robert D
authors.initials: RD
authors.lastname: Burk
authors.forename: Kathryn
authors.initials: K
authors.lastname: Anastos
authors.forename: Leslie Stewart
authors.initials: LS
authors.lastname: Massad
authors.forename: Isam-Eldin
authors.initials: IE
authors.lastname: Eltoum
authors.forename: Xiaonan
authors.initials: X
authors.lastname: Xue
authors.forename: Gypsyamber
authors.initials: G
authors.lastname: DʼSouza
authors.forename: Lisa
authors.initials: L
authors.lastname: Flowers
authors.forename: Joel M
authors.initials: JM
authors.lastname: Palefsky
authors.forename: Lisa
authors.initials: L
authors.lastname: Rahangdale
authors.forename: Howard D
authors.initials: HD
authors.lastname: Strickler
authors.forename: Ighovwerha
authors.initials: I
authors.lastname: Ofotokun
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D061466:Lopinavir / Q000008:administration & dosage / Q000627:therapeutic use*; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000150:complications*; D002583:Uterine Cervical Neoplasms / Q000821:virology
chemical_list: D019380:Anti-HIV Agents; D061466:Lopinavir